- Home
- HCVIU
as 11-15-2024 4:00pm EST
Stocks
Hennessy Capital Investment Corp VI is a shell company.
| Founded: | N/A | Country: | N/A |
| Employees: | 2 | City: | ZEPHYR COVE |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest HENNESSY CAP INVESTMENT COR News
HCVIU Breaking Stock News: Dive into HCVIU Ticker-Specific Updates for Smart Investing
MT Newswires
2 months ago
Hennessy Capital Shareholders Approve Extension of Deadline for Business Combination
GlobeNewswire
2 months ago
Hennessy Capital Investment Corp. VI Announces Stockholder Approval of Extension of Deadline to Complete Business Combination
GlobeNewswire
2 months ago
Hennessy Capital Investment Corp. VI Announces Postponement of its Special Meeting of Stockholders to 10:00 A.M. ET on September 30
MT Newswires
5 months ago
Hennessy Capital Investment, Namib Minerals Sign Business Combination Agreement
GlobeNewswire
5 months ago
Namib Minerals, an Established African Gold Producer, to Become Publicly Traded Through Business Combination With Hennessy Capital Investment Corp. VI
Simply Wall St.
9 months ago
Favourable Signals For VYNE Therapeutics: Numerous Insiders Acquired Stock
GlobeNewswire
10 months ago
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024
GlobeNewswire
10 months ago
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
Compare HCVIU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCVIU HENNESSY CAP INVESTMENT COR - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.